Chairs Shuffling

[Guest]

what about Baylor? I heard it is going to be Mumaneni

[Guest]

(04-26-2020, 01:11 AM)Guest Wrote: what about Baylor? I heard it is going to be Mumaneni

It’s Ganesh Rao versus Aghi versus Khalessi versus Mummaneeeni

[Guest]

(04-26-2020, 02:03 AM)Guest Wrote:

(04-26-2020, 01:11 AM)Guest Wrote: what about Baylor? I heard it is going to be Mumaneni

It’s Ganesh Rao versus Aghi versus Khalessi versus Mummaneeeni

How about Sheth?

[Guest]

1. Berger to step down soon.
2. New faculty search to replace McDermott skull base/meningiomas. Saigal is in the mix.
3. Mummaneni is front choice as chair. Manley is too old, and Aghi is too nice to be chairman. Also wants to focus on his lab.
4. Eddie Chang wants to focus on research but is fielding other programs as director of functional - higher salary + lower cost of living no matter where he goes. Word on the street is Neuralink is interested in working with him in a higher capacity. With the addition of Wang, there is a glut of functional neurosurgeons at UCSF.
5. Mike Lim as chair of Stanford + JFM as skull base will revitalize their tumor program. Vascular to remain average. Abla at UCSF is soaking up the open vascular cases.
6. Both UCSF and Stanford have hired several spine faculty over the past two years; power dynamics are going to be interesting as both institutions are heavily promoting their satellite offices throughout the Bay Area.

[Guest]

(04-29-2020, 01:15 AM)Guest Wrote: 1. Berger to step down soon.
2. New faculty search to replace McDermott skull base/meningiomas. Saigal is in the mix.
3. Mummaneni is front choice as chair. Manley is too old, and Aghi is too nice to be chairman. Also wants to focus on his lab.
4. Eddie Chang wants to focus on research but is fielding other programs as director of functional - higher salary + lower cost of living no matter where he goes. Word on the street is Neuralink is interested in working with him in a higher capacity. With the addition of Wang, there is a glut of functional neurosurgeons at UCSF.
5. Mike Lim as chair of Stanford + JFM as skull base will revitalize their tumor program. Vascular to remain average. Abla at UCSF is soaking up the open vascular cases.
6. Both UCSF and Stanford have hired several spine faculty over the past two years; power dynamics are going to be interesting as both institutions are heavily promoting their satellite offices throughout the Bay Area.

who is saigal?

[Guest]

(04-29-2020, 01:29 AM)Guest Wrote:

(04-29-2020, 01:15 AM)Guest Wrote: 1. Berger to step down soon.
2. New faculty search to replace McDermott skull base/meningiomas. Saigal is in the mix.
3. Mummaneni is front choice as chair. Manley is too old, and Aghi is too nice to be chairman. Also wants to focus on his lab.
4. Eddie Chang wants to focus on research but is fielding other programs as director of functional - higher salary + lower cost of living no matter where he goes. Word on the street is Neuralink is interested in working with him in a higher capacity. With the addition of Wang, there is a glut of functional neurosurgeons at UCSF.
5. Mike Lim as chair of Stanford + JFM as skull base will revitalize their tumor program. Vascular to remain average. Abla at UCSF is soaking up the open vascular cases.
6. Both UCSF and Stanford have hired several spine faculty over the past two years; power dynamics are going to be interesting as both institutions are heavily promoting their satellite offices throughout the Bay Area.

who is saigal?

Lol ok Mummaneni was eliminated round 1. Edward Chang is front runner followed by Aghi

[Guest]

Saigal is a former UCSF resident, currently a *spine* attending at UW. Logical choice to replace McDermott, the skull base is just the spine's hat.oe63b

[Guest]

Maybe he meant Shekhar?

[Guest]

(04-29-2020, 01:15 AM)Guest Wrote: 1. Berger to step down soon.
2. New faculty search to replace McDermott skull base/meningiomas. Saigal is in the mix.
3. Mummaneni is front choice as chair. Manley is too old, and Aghi is too nice to be chairman. Also wants to focus on his lab.
4. Eddie Chang wants to focus on research but is fielding other programs as director of functional - higher salary + lower cost of living no matter where he goes. Word on the street is Neuralink is interested in working with him in a higher capacity. With the addition of Wang, there is a glut of functional neurosurgeons at UCSF.
5. Mike Lim as chair of Stanford + JFM as skull base will revitalize their tumor program. Vascular to remain average. Abla at UCSF is soaking up the open vascular cases.
6. Both UCSF and Stanford have hired several spine faculty over the past two years; power dynamics are going to be interesting as both institutions are heavily promoting their satellite offices throughout the Bay Area.

"Too nice" to be chairman?

[Guest]

Is Nakaji out at Arizona?

https://neurosurgery.arizona.edu/directory